OncoSenX
San Diego, USA
|
Description:
OncoSenX is a late stage pre-clinical cancer company which targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The company's treatment delivers a simple program that induces apoptosis in cancerous cells.
OncoSenX is a late stage pre-clinical cancer company which targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The company's treatment delivers a simple program that induces apoptosis in cancerous cells.